Home › Nasopharyngeal Carcinoma › Pennsylvania › Pittsburgh
Nasopharyngeal Carcinoma clinical trials in Pittsburgh, PA
3 studies for Nasopharyngeal Carcinoma are looking for participants at sites in and around Pittsburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
RecruitingPhase 2
- UPMC Hillman Cancer Center, Pittsburgh
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
RecruitingPhase 2
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RecruitingPhase 2
- UPMC-Saint Margaret, Pittsburgh
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
- UPMC-Shadyside Hospital, Pittsburgh
- and 5 more
Nasopharyngeal Carcinoma trials in other cities
- Atlanta, GA6 studies
- Houston, TX3 studies
- Richmond, VA3 studies
- Cincinnati, OH3 studies
- Los Angeles, CA3 studies
- Washington, DC3 studies
- Chicago, IL3 studies
- San Francisco, CA3 studies
- Charlotte, NC3 studies
- Oklahoma City, OK3 studies
- Milwaukee, WI3 studies
Other studies in Pittsburgh
- Non-Small Cell Lung Cancer48 studies
- Cancer (all types)41 studies
- Breast Cancer39 studies
- Colorectal Cancer32 studies
- Metastatic Cancer31 studies
- Melanoma31 studies
- Ovarian Cancer30 studies
- Endometrial Cancer23 studies
- Prostate Cancer23 studies
- Lung Cancer23 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Stroke22 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.